Page last updated: 2024-10-21

ethylisopropylamiloride and B-Cell Chronic Lymphocytic Leukemia

ethylisopropylamiloride has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies

ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wiley, JS1
Jamieson, GP1
Mayger, W1
Cragoe, EJ1
Jopson, M1
Gaidano, G1
Ghigo, D1
Schena, M1
Bergui, L1
Treves, S1
Turrini, F1
Cappio, FC1
Bosia, A1

Other Studies

2 other studies available for ethylisopropylamiloride and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Extracellular ATP stimulates an amiloride-sensitive sodium influx in human lymphocytes.
    Archives of biochemistry and biophysics, 1990, Aug-01, Volume: 280, Issue:2

    Topics: Adenosine Triphosphate; Amiloride; Biological Transport; Dose-Response Relationship, Drug; Humans; H

1990
Na+/H+ exchange activation mediates the lipopolysaccharide-induced proliferation of human B lymphocytes and is impaired in malignant B-chronic lymphocytic leukemia lymphocytes.
    Journal of immunology (Baltimore, Md. : 1950), 1989, Feb-01, Volume: 142, Issue:3

    Topics: Aged; Amiloride; B-Lymphocytes; Carrier Proteins; Child; Female; Humans; Hydrogen-Ion Concentration;

1989